Until 15 January 2012, young researchers working in Europe who are not older than 35 years are invited to apply for the Eppendorf Award for Young European Investigators. This highly prestigious prize was first established in 1995. It acknowledges outstanding contributions to biomedical research in Europe based on methods of molecular biology, including novel analytical concepts.
Sectra and Royal Philips Electronics have signed an agreement under which Philips will acquire Sectra’s mammography modality operations. The cash purchase consideration amounts to EUR 57.5 million on cash and debt-free basis. The agreement also includes an additional possible earn-out EUR 12.5 million in accordance with specially agreed terms and conditions.
HI-RTE allows the assessment and real-time colour display of tissue elasticity. The current generation ultrasound modality has proven applications in breast, prostate, thyroid and pancreatic disease and where diagnostic biopsy is indicated, HI-RTE allows more accurate localization and targeting of lesions.
How low? During the GE Healthcare Lunch Symposium of GE Healthcare at this year’s ECR in Vienna, Michael Maher, Professor of Radiology at the University College, Cork, provided an answer: 1.2 millisievert – at least for abdominal CT scans in patients with Crohn’s disease.
A major public hospital has become the first in Paris to be equipped with a Gamma Knife, the device that enables the surgeon to operate on the brain with no blade or blood involved.
On average, European countries possess 17 MRI machines per one million people. With only 9.4 MRI machines per million people, France ranks between Portugal and Turkey, putting it among the least well-equipped in Europe, according to the Société Française de Radiologie.
Although the 17 lectures delivered at this year‘s Medical Technology Congress in Berlin, Germany, focused on topics ranging from experimental and clinical research to routine daily diagnostic methods, the pervading interest was in the improvement, development and distribution of non-invasive imaging devices and corresponding software.
United Kingdom – A call has been made for tighter regulatory controls to ensure the safety regulation of medical devices, following joint investigations carried out by the British Medical Journal and the Channel 4 TV programme Dispatches, which were televised and published online at BMJ.com this May.
PredictAD is an EU-funded research project that develops objective and efficient methods for enabling earlier diagnosis of Alzheimer's disease. Diagnosis requires a holistic view of the patient combining information from several sources, such as, clinical tests, imaging and blood samples.
Breast cancer is the most common form of cancer in women. Evaluation of the axillary lymph nodes is essential to insure complete cancer removal. Fluorescence imaging instead of radioisotopes is an innovative method for sentinel lymph node detection.
Dr Bill Svensson believes that elastography has the potential to improve diagnosis of breast cancer, reduce the number of false positives in the detection of the condition and also lead to fewer biopsies performed as accuracy of imaging improves further. This June he highlighted the potential of elastography and the developments in the imaging modality at two sessions at the United Kingdom…
Every medical congress is an opportunity for the manufacturers to showcase their products. This year’s congress of the German Röntgen Society was no exception -- and one innovation particularly caught the attention of our European Hospital team: positron emission mammography, PEM for short.
The clinical informatics firm ICNet International Ltd, which develops case management and surveillance software, has produced a software package using the SSI (Surgical Site infection surveillance) Monitor to combine information about patient movements in a hospital with data held by the laboratory and theatre systems -- and to alert staff if a patient is either infected or at risk of contracting…
Although powerful, new, targeted treatments are regularly introduced to cancer clinics, choices for the first-line treatment of invasive breast cancer normally lie between preventive surgery and chemotherapy. A recent American study used genomic prediction combining multiple signatures to determine outcomes to standard chemotherapy.
Facing the fundamental changes that laboratory medicine is undergoing, in early June Roche Diagnostics Deutschland GmbH invited 50 high-profile speakers to a six-day symposium to discuss current research, economic and diagnostic issues in lab medicine with a professional audience. Report: Karoline Laarmann
Morbid obesity is a chronic, lifelong, multifactorial, constitutional disease with negative medical, psychological, physical, social and economic side-effects. Obesity-related secondary diseases are Type 2 diabetes mellitus (T2DM), cardiovascular diseases such as hypertension or sleep apnoea. Report: Holger Zorn
One year ago interventional cardiologists raised champagne glasses to celebrate the first publication of clinical evidence showing that transcatheter valve implants (TAVI) is safe and effective. In May at EuroPCR 2011, cardiologists raised magnifying glasses to look closer at further clinical results. John Brosky reports from Paris
Initially meant to bridge the gap before a heart transplant is performed, today ventricular assist devices (VADs) are increasingly considered ‘a lasting therapy option’, according to Professor Heinrich Schima, Head of the Centre for Medical Physics and Biomedical Technology at the Medical University of Vienna.
Given the increase in overweight or obese populations (estimated at around 50% in Europe alone), hospital equipment that supports patients must be tried, tested and proved to be robust indeed. Like many hospital equipment manufacturers, the Tuttlingen-based firm Berchtold is well aware of this growing concern, already providing components and accessories for obesity surgery.
Hitachi Medical Corporation is delighted to announce that its HI VISION Avius ultrasound platform has been selected as a recipient of the iF product design award 2011 and is proud to now carry the iF design quality label.
The European Society of Cardiology (ESC) is calling for a single, co-ordinated European system to oversee the evaluation and approval of medical devices. The call is being made in a paper published online in the European Heart Journal reporting on a conference held by the ESC in January 2011 looking to increase the input of medical experts in developing medical device policy.
Edwards Lifesciences Corporation, a global leader in the science of heart valves and hemodynamic monitoring, announced that interim data from a multi-center European prospective study of the investigational EDWARDS INTUITY Valve System showed promising results for patients undergoing surgical aortic valve replacement (AVR).
IBA Group, a leader in advanced cancer diagnosis and therapy technologies and Royal Philips Electronics, announced they have entered into an agreement to create state of the art patient-centric proton therapy centers.
Shimadzu, world-wide manufacturer of diagnostic imaging equipment, has introduced the first wireless flat-panel detector (FPD) for its mobile, fully digital X-ray system MobileDaRt Evolution. This new CXDI-70C detector generation is the next evolutionary step for mobile X-ray applications.
Carestream Health is one of the first healthcare IT providers to conduct pre-launch testing of the new Intel® Xeon® processor E7 product family in its industry-leading medical image management, archiving and distribution systems. These tests indicate the new high-performance processors can equip Carestream Health’s PACS and SuperPACS™ Architecture to deliver responsive access to a larger…
